When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?

被引：7
|
作者：
Kamar, N. [1 ,2 ,3 ]
Marion, O. [1 ]
Izopet, J. [2 ,3 ,4 ]
机构：
[1] CHU Rangueil, Dept Nephrol & Organ Transplantat, F-31054 Toulouse, France
[2] CHU Purpan, IFR BMT, INSERM U1043, Toulouse, France
[3] Univ Toulouse 3, F-31062 Toulouse, France
[4] CHU Purpan, Virol Lab, Toulouse, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷 / 02期
关键词：
clinical research; practice; infectious disease; infection and infectious agents; viral: hepatitis; liver disease; RECIPIENTS;
D O I：
10.1111/ajt.13567
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：727 / 727
页数：1
相关论文
共 50 条
  • [31] Hepatitis E: when to treat and how to treat
    Abbas, Zaigham
    Afzal, Rafia
    ANTIVIRAL THERAPY, 2014, 19 (02) : 125 - 131
  • [32] Hepatitis E virus infection can evolve to chronic hepatitis in organ-transplant patients
    Kamar, N.
    Peron, J. M.
    Ouezzani, L.
    Mansuy, J. M.
    Selves, J.
    Guitard, J.
    Cointault, O.
    Bureau, C.
    Durand, D.
    Vinel, J. P.
    Izopet, J.
    Rostaing, L.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S70 - S71
  • [33] Hepatitis E virus infection and ribavirin treatment in patients with chronic lymphocytic leukemia receiving ibrutinib
    Protin, C.
    Abravanel, F.
    Laurent, G.
    Tavitian, S.
    Oberic, L.
    Izopet, J.
    Martin-Blondel, G.
    Ysebaert, L.
    Alric, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S250 - S250
  • [34] The Prevalence of Hepatitis E Virus Infections and Ribavirin Therapy in Heart Transplant Recipients
    Okamura, K.
    Nawata, K.
    Kimura, M.
    Kinoshita, O.
    Masuzawa, A.
    Yamauchi, H.
    Hirata, Y.
    Owada, Y.
    Oshiro, Y.
    Okamoto, H.
    Ohkohchi, N.
    Ono, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S78 - S78
  • [35] An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients
    Kamar, Nassim
    Lhomme, Sebastien
    Abravanel, Florence
    Cointault, Olivier
    Esposito, Laure
    Cardeau-Desangles, Isabelle
    Del Bello, Arnaud
    Doerr, Gaelle
    Lavayssiere, Laurence
    Nogier, Marie Beatrice
    Guitard, Joelle
    Ribes, David
    Goin, Anne Laure
    Broue, Pierre
    Metsu, David
    Saune, Karine
    Rostaing, Lionel
    Izopet, Jacques
    TRANSPLANTATION, 2015, 99 (10) : 2124 - 2131
  • [36] Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients
    Klaembt, Verena
    Panning, Marcus
    Seidl, Maximilian
    Haeffner, Karsten
    Pohl, Martin
    PEDIATRIC TRANSPLANTATION, 2018, 22 (04)
  • [37] Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
    Gallacher, Jennifer
    Taha, Yusri
    Filipe, Ana da Silva
    Ijaz, Samreen
    McPherson, Stuart
    IDCASES, 2023, 32
  • [38] Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection
    Marion, Olivier
    Abravanel, Florence
    Izopet, Jacques
    Kamar, Nassim
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (02)
  • [39] HEPATITIS E VIRUS INFECTION IN HEART TRANSPLANT RECIPIENTS: HEV SEROPREVALENCE, RISK FOR CHRONIC COURSES AND EFFICACY OF RIBAVIRIN TREATMENT
    Pischke, Sven
    Stiefel, Penelope
    Bremer, Birgit
    Suneetha, Pothakamuri V.
    Franz, Beate
    Heim, Albert
    Ganzenmueller, Tina
    Schlue, Jerome
    Horn-Wichmann, Ruediger
    Raupach, Regina
    Scheibner, Yves
    Haverich, Axel
    Manns, Michael P.
    Bara, Christoph L.
    Wedemeyer, Heiner
    HEPATOLOGY, 2011, 54 : 617A - 617A
  • [40] Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: A case report
    Waldenström J.
    Castedal M.
    Konar J.
    Karason K.
    Lagging M.
    Norder H.
    Journal of Medical Case Reports, 9 (1)
12345